Importer of Controlled Substances; Notice of Application, 51398-51399 [2011-21117]
Download as PDF
<![CDATA[
51398
Federal Register / Vol. 76, No. 160 / Thursday, August 18, 2011 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
United States and Rhode Island v. City of
Newport, Rhode Island, Civil Action No. 08–
265S, was filed with the United States
District Court for Rhode Island.
In this action, the United States and
the other plaintiffs sought penalties and
injunctive relief for the Defendant’s
violations of the Clean Water Act, 33
U.S.C. 1251 et seq., at its sewer system
and water pollution control plant. To
resolve the United States’ claims, the
Defendants will pay a penalty of
$170,000, and will undertake extensive
work to its sewer system and water
pollution control plant to eliminate
violations of the Clean Water Act.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the Consent Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to either:
Environment Rhode Island et al. and the
United States and Rhode Island v. City
of Newport, Rhode Island, Civil Action
No. 08–265S, or D.J. Ref. 90–5–1–1–
09855. The Consent Decree may be
examined at the Office of the United
States Attorney, District of Rhode
Island, Fleet Center, 50 Kennedy Plaza,
8th Floor, Providence, Rhode Island
02903, and at the United States
Environmental Protection Agency, 5
Post Office Square, Suite 100, Boston,
Massachusetts 02109. During the public
comment period, the Consent Decree
may also be examined on the following
Department of Justice Web site, https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
Consent Decree may also be obtained by
mail from the Consent Decree Library,
P.O. Box 7611, U.S. Department of
Justice, Washington, DC 20044–7611 or
by faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check,
payable to the U.S. Treasury, in the
amount of $21.50 (25 cents per page
reproduction cost), or, if by e-mail or
fax, forward a check in the applicable
amount to the Consent Decree Library at
the stated address.
Ronald Gluck,
Assistant Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 2011–20996 Filed 8–17–11; 8:45 am]
BILLING CODE 4410–15–P
VerDate Mar<15>2010
16:04 Aug 17, 2011
Jkt 223001
DEPARTMENT OF JUSTICE
Notice of Proposed Partial Consent
Decree Under the Comprehensive
Environmental Response,
Compensation, and Liability Act and
the Clean Air Act
Notice is hereby given that on August
12, 2011, a proposed Partial Consent
Decree in United States v. C.A.I., Inc., et
al., Civil Action No. 1:10–cv–10390–
GAO, was lodged with the United States
District Court for the District of
Massachusetts.
The proposed Partial Consent Decree
will settle the United States’ claims on
behalf of the U.S. Environmental
Protection Agency (‘‘EPA’’) against
Defendants C.A.I., Inc. (‘‘CAI’’),
Sartorelli Realty, LLC (‘‘SRLLC’’), and
Roy A. Nelson as Trustee of Nelson
Danvers Realty Trust (‘‘NDRT’’),
pursuant to Section 107 of the
Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’), 42 U.S.C. 9607, and
Sections 112(r) and 114(a) of the Clean
Air Act (‘‘CAA’’), 42 U.S.C. 7412(r),
7414(a), with respect to the Danversport
Superfund Site, a former inks and paint
products manufacturing facility, in
Danvers, Massachusetts (‘‘Site’’).
Pursuant to the Partial Consent Decree,
based on demonstrations of limited
financial resources: CAI will pay
$400,000, including $300,000 in
response costs under CERCLA and
$100,000 as a civil penalty under the
CAA; SRLLC will pay $150,000 in
response costs; NDRT will pay $140,000
in response costs; and the settling
defendants will transfer to the United
States funds from an escrow account
totaling approximately $27,000 as of
March 2011. In addition, SRLLC and
NDRT will make best efforts to sell the
Site property and will transfer all net
sales proceeds to the United States.
Finally, the settling defendants will pay
the United States 90% of any net
proceeds from the resolution of other
Site-related proceedings, up to the total
amount of the United States’
unreimbursed response costs. The
proposed Partial Consent Decree,
together with a Partial Consent Decree
between the United States and
Defendant Arnel Company, Inc. entered
on July 1, 2011, will resolve this action
in its entirety.
The Department of Justice will receive
comments relating to the proposed
Partial Consent Decree for a period of 30
days from the date of this publication.
Comments on the Partial Consent
Decree should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. C.A.I., Inc., et al., Civil Action
No. 1:10–cv–10390–GAO, D.J. Ref. 90–
11–2–09184 & 90–11–2–09184/1.
During the public comment period,
the proposed Partial Consent Decree
may be examined at the following
Department of Justice Web site: https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
proposed Partial Consent Decree may
also be obtained by mail from the
Consent Decree Library, P.O. Box 7611,
U.S. Department of Justice, Washington,
DC 20044–7611 or by faxing or emailing a request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax number
(202) 514–0097, phone confirmation
number (202) 514–1547. If requesting a
copy by mail from the Consent Decree
Library, please enclose a check in the
amount of $15.75 ($0.25 per page
reproduction cost) payable to the U.S.
Treasury or, if requesting by e-mail or
fax, forward a check in that amount to
the Consent Decree Library at the abovereferenced address.
Ronald G. Gluck,
Assistant Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 2011–21002 Filed 8–17–11; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on May 4, 2011, Cambrex Charles
City, Inc., 1205 11th Street, Charles City,
Iowa 50616–3466, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Drug
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
The company plans to import the
listed controlled substances to
manufacture a bulk intermediate for sale
to its customers. With regards to the
phenylacetone, the company plans to
use it as a base material in the bulk
manufacture of another controlled
substance.
E:\FR\FM\18AUN1.SGM
18AUN1
51399
Federal Register / Vol. 76, No. 160 / Thursday, August 18, 2011 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw, and coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act 21 U.S.C.
952(a)(2)(B) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 19, 2011.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745, all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: August 11, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–21117 Filed 8–17–11; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
16:04 Aug 17, 2011
Jkt 223001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on May 4,
2011, Cambrex Charles City, 1205 11th
Street, Charles City, Iowa 50616–3466,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Noroxymorphone (9668), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
basic class of controlled substance in
bulk for sale to its customers.
Any bulk manufacturers who are
presently, or are applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 19, 2011.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745, all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Dated: August 10, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–21121 Filed 8–17–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to Title 21, of the CFR
1301.34(a), this is notice that on June 8,
2011, Aptuit, 10245 Hickman Mills
Drive, Kansas City, Missouri 64137,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the following basic classes of controlled
substances:
Drug
Marihuana (7360) .........................
Poppy Straw Concentrate (9670)
Schedule
I
II
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form for packaging for a clinical trial
study. In addition, the company also
plans to import an ointment for the
treatment of wounds which contain
trace amounts of the controlled
substances normally found in poppy
straw concentrate for packaging and
labeling for clinical trials.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw or coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417(2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration, and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 76, Number 160 (Thursday, August 18, 2011)]
[Notices]
[Pages 51398-51399]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21117]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on May 4, 2011, Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616-3466, made application by renewal to
the Drug Enforcement Administration (DEA) for registration as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture a bulk intermediate for sale to its customers. With regards
to the phenylacetone, the company plans to use it as a base material in
the bulk manufacture of another controlled substance.
[[Page 51399]]
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw, and coca
leaves. As explained in the Correction to Notice of Application
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and
requests for hearings on applications to import narcotic raw material
are not appropriate.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act 21 U.S.C. 952(a)(2)(B) may, in the
circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than September 19, 2011.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745, all applicants for
registration to import a basic class of any controlled substance in
schedule I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: August 11, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-21117 Filed 8-17-11; 8:45 am]
BILLING CODE 4410-09-P
